Form 8.3 - Allergan plc

LONDON--()-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Millennium International Management LP

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

IE00BY9D5467

Date of dealing

1st May 2020

2. INTERESTS AND SHORT POSITIONS

a. Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,451,258

(1.352%)

 

4,256

(0.001%)

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

-

-

Total

4,451,258

(1.352%)

 

4,256

(0.001%)

 

b. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

1. DEALINGS (Note 4)

a. Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit (Note 5)

(USD)

Sale

19,240

189.74

Purchase

38,439

189.74

Sale

14

189.29

Sale

349

189.19

Sale

211

189.20

Sale

289

189.18

Sale

211

189.31

Sale

81

189.26

Sale

111

189.15

Sale

456

189.24

Sale

300

189.22

Sale

53

189.16

Sale

100

189.17

Sale

400

189.33

Sale

200

189.30

Sale

153

189.41

Sale

100

189.35

Sale

11

189.21

Sale

174

189.27

Sale

200

189.38

Sale

47

189.47

Sale

100

189.23

Sale

100

189.34

Sale

159

189.36

Sale

200

189.44

Sale

278

189.32

Sale

212

189.40

Sale

200

189.39

Sale

144

189.37

Purchase

107

189.79

Sale

100

189.46

Purchase

397

187.13

Sale

648

189.53

Purchase

397

187.51

Purchase

197

188.75

Sale

72

189.26

Purchase

139

189.27

Sale

277

189.48

Purchase

210

188.16

Purchase

9,351

189.74

Purchase

1,652

188.66

Purchase

103

187.52

Sale

85

189.61

Sale

360

189.46

Purchase

209

187.79

Sale

209

189.74

Sale

53

189.72

Purchase

119

189.54

Purchase

192

189.55

Purchase

100

189.29

Sale

5

189.29

Purchase

1,012

189.53

Purchase

1,603

189.52

Purchase

827

189.51

Purchase

100

189.43

Sale

200

189.43

Purchase

545

189.49

Sale

65

189.49

Sale

192

186.82

Purchase

100

189.19

Purchase

602

189.50

Sale

120

189.50

Purchase

100

189.20

Purchase

100

189.18

Sale

158

189.64

Sale

10

189.31

Purchase

100

189.26

Purchase

300

189.15

Purchase

200

189.24

Sale

22

189.24

Purchase

100

189.22

Purchase

100

189.33

Sale

100

189.33

Purchase

39

189.28

Purchase

100

189.30

Purchase

400

189.21

Sale

12

189.21

Sale

1

189.38

Sale

46

189.23

Purchase

100

189.34

Purchase

100

189.32

Sale

138

189.65

Purchase

93,868

189.74

Sale

38,439

189.74

Sale

100

189.37

Purchase

100

189.14

Purchase

111

189.63

Sale

15

189.63

Sale

53

189.71

Sale

6

189.70

Sale

73

189.42

Sale

39

189.56

Sale

11

189.67

Sale

100

189.61

Sale

12

189.57

Sale

74,628

189.74

i. Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

b. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

 

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure

4th May 2020

Contact name

Milos Naumovic

Telephone number

+44 203 650 8203

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 

Short Name: MILLENNIUM PARTNERS, L.P.
Category Code: RET
Sequence Number: 698799
Time of Receipt (offset from UTC): 20200504T104358+0100

Contacts

Millennium Partners, L.P.

Contacts

Millennium Partners, L.P.